Clinical evaluation of nebulized verapamil in out‐patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease

Clinical evaluation of nebulized verapamil in out‐patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease

Abstract Objective Chronic obstructive pulmonary disease (COPD) is associated with many health complications, including pulmonary hypertension (PH). Although oral calcium channel blockers have shown promising results in managing COPD‐induced PH, significant systemic side effects may limit their use...

Full description

Bibliographic Details
Main Authors: Fanak Fahimi, Guitti Pourdowlat, Neda Behzadnia, Sahar Sadigh Mostofi, Aida Sefidani Forough, Omid Parto, Ayda Esmaeili
Format: Article
Language:English
Published: Wiley 2022-12-01
Series:The Clinical Respiratory Journal
Subjects:
calcium channel blocker
COPD
inhaled verapamil
nebulization
pulmonary function test
pulmonary hypertension
Online Access:https://doi.org/10.1111/crj.13551

Internet

https://doi.org/10.1111/crj.13551

Similar Items